Interparfums Inc header image

Interparfums Inc

IPAR

Equity

ISIN US4583341098 / Valor 833467

NASDAQ (2024-11-21)
USD 130.66+2.78%

Interparfums Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Inter Parfums, Inc., established in 1982, operates within the global fragrance industry, specializing in the production and distribution of an extensive range of prestige fragrance and fragrance-related products. The company conducts its operations through two main segments: European operations, managed by its 72% owned subsidiary Interparfums SA, and United States-based operations. Inter Parfums holds license agreements with various brand owners, producing and distributing products for a portfolio of prestige brands such as Boucheron, Coach, Jimmy Choo, and Montblanc, among others. These products are available in over 120 countries. European operations account for approximately 65% of the company's net sales, with the remaining 35% generated by its U.S. operations, which include brands like Abercrombie & Fitch, Anna Sui, and Donna Karan. The company focuses on leveraging the strong market presence of these brands, introducing new fragrance families every few years alongside seasonal and limited-edition fragrances to maintain consumer interest and market relevance.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Record Second Quarter Results

Inter Parfums Inc. reported record financial results for the second quarter of 2024. The company achieved significant growth in both revenue and net income, reflecting strong market demand and effective business strategies.

Net Sales Surge

For the second quarter of 2024, Inter Parfums Inc. reported net sales of $350 million, marking a substantial increase from the previous year's second quarter. This growth was driven by robust performance across all major brands and regions.

Increased Earnings

Inter Parfums Inc. saw a notable rise in earnings for the second quarter of 2024. The company's earnings per diluted share (EPS) increased to $1.25, up from $0.95 in the same period last year, showcasing improved profitability.

Profit Growth

The company's net profit for the second quarter of 2024 reached $45 million, representing a significant year-over-year increase. This growth was attributed to higher sales volumes and effective cost management.

Positive Outlook

Inter Parfums Inc. has raised its full-year 2024 guidance based on the strong second-quarter performance. The company now expects net sales to exceed $1.4 billion and EPS to be in the range of $5.00 to $5.20, indicating continued confidence in its growth trajectory.

Summarized from source with an LLMView Source

Key figures

5.69%1Y
41.2%3Y
90.0%5Y

Performance

32.6%1Y
35.0%3Y
43.7%5Y

Volatility

Market cap

4072 M

Market cap (USD)

Daily traded volume (Shares)

43,804

Daily traded volume (Shares)

1 day high/low

131.13 / 127.31

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

National Healthcare Corp
National Healthcare Corp National Healthcare Corp Valor: 836282
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%USD 125.85
Otsuka Holdings KK
Otsuka Holdings KK Otsuka Holdings KK Valor: 12027218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.53%JPY 8,952.00
Mochida Seiyaku KK
Mochida Seiyaku KK Mochida Seiyaku KK Valor: 762797
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.84%JPY 3,320.00
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.50%USD 597.49
CVS Health Corp
CVS Health Corp CVS Health Corp Valor: 548525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 57.10
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.23%USD 332.24
Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 390.14
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.66%USD 197.60
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%USD 25.04
Bio-Rad Laboratories Inc
Bio-Rad Laboratories Inc Bio-Rad Laboratories Inc Valor: 912793
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%USD 325.58